Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

113
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
113
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

75
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
75
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

126
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
126
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

131
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
131
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

112
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
112
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

59
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
59

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An exploratory open-label multicentre phase I/II trial evaluating the safety and efficacy of postnatal or prenatal and postnatal administration of allogeneic expanded fetal mesenchymal stem cells for the treatment of severe osteogenesis imperfecta in infants and fetuses: the BOOSTB4 trial protocol.

BMJ open·2024
Same author

The need for a standard for informed consent for collection of human fetal material.

Stem cell reports·2022
Same author

The ethics of regenerative medicine.

Biologia futura·2021
Same author

[The priority-setting platform and its conditions].

Lakartidningen·2019
Same author

Paternal consent in prenatal research: ethical aspects.

Medicine, health care, and philosophy·2019
Same author

Ethical Considerations in Crossing the Xenobarrier.

Methods in molecular biology (Clifton, N.J.)·2019

Related Experiment Video

Updated: Nov 11, 2025

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery
08:43

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery

Published on: February 14, 2017

11.2K

A Future for Migrants with Acute Heart Problems Seeking Asylum?

Göran Hermerén

    Cambridge Quarterly of Healthcare Ethics : CQ : the International Journal of Healthcare Ethics Committees
    |March 25, 2021
    PubMed
    Summary

    Migrants with acute heart conditions seeking asylum face uncertain healthcare access. This paper explores ethical challenges and rights concerning essential medical services for vulnerable populations.

    Keywords:
    Geneva declarationIstanbul declarationcross-border healthcareethicshealthcare needheart transplantationmigrantspoliticsrights of asylum seekers

    More Related Videos

    Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
    10:05

    Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

    Published on: July 7, 2016

    8.5K
    Implantation of Total Artificial Heart in Congenital Heart Disease
    07:27

    Implantation of Total Artificial Heart in Congenital Heart Disease

    Published on: July 18, 2014

    24.9K

    Related Experiment Videos

    Last Updated: Nov 11, 2025

    Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery
    08:43

    Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery

    Published on: February 14, 2017

    11.2K
    Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
    10:05

    Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

    Published on: July 7, 2016

    8.5K
    Implantation of Total Artificial Heart in Congenital Heart Disease
    07:27

    Implantation of Total Artificial Heart in Congenital Heart Disease

    Published on: July 18, 2014

    24.9K

    Area of Science:

    • Medical Ethics
    • Public Health Policy
    • Immigration Law

    Background:

    • Undocumented migrants with acute cardiac conditions present complex ethical and logistical challenges.
    • The increasing number of individuals seeking asylum raises concerns about their access to critical healthcare services.
    • Similar ethical dilemmas arise for migrants with other acute medical needs.

    Purpose of the Study:

    • To examine the ethical considerations surrounding healthcare provision for migrants with acute heart problems.
    • To explore the extent of healthcare services migrants are entitled to in their host country.
    • To analyze the multifaceted challenges in providing care to vulnerable migrant populations.

    Main Methods:

    • Literature review of ethical frameworks and legal precedents.
    • Analysis of policy documents related to migrant healthcare access.
    • Exploration of arguments for and against various ethical positions.

    Main Results:

    • Identifies significant ethical dilemmas concerning organ transplantation access and public organ donation willingness.
    • Highlights issues of justice, fairness, and potential conflicts between law, politics, and ethics.
    • Examines communication challenges between healthcare providers and administrative agencies.

    Conclusions:

    • Urgent need for clear ethical guidelines and policies for migrant healthcare.
    • Addressing these issues requires international cooperation and interdisciplinary approaches.
    • Ensuring equitable access to care is crucial for vulnerable migrant populations.